Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05063474 · ClinicalTrials.gov registry record
Microvascular Reactivity in Peripheral Artery Disease
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 3
- Enrollment target
NCT05063474: Clinical Trial study, sponsored by Columbia University.
NCT05063474 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05063474 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
Peripheral Artery Disease (PAD) is a major risk factor for lower limb amputation. Microvascular reactivity assessed with near-infrared spectrometry has been studied in people with PAD but not in people with limb loss (PLL) who have PAD. The purpose of this research is to explore whether near-infrared spectrometry measures can contribute to identifying people at risk for amputation. Specific aims include: 1) Determine the test-retest reliability of near-infrared spectrometry measures in people with peripheral artery disease with or without major unilateral amputation. 2) Determine construct validity of near-infrared spectrometry measures compared to 6-Minute Walk Test, and time to claudication onset; and self-reported prosthetic mobility in people with transtibial amputation. This methodologic prospective study with repeated assessments and long term phone follow-up every year to identify any subjects that undergo revascularization or amputation will include 2 groups of subjects: a PAD group enrolled from an out-patient walking program, and a PLL+PAD group who receive no care but have their walking step counts monitored.
Primary Outcome
Near Infrared Spectrometry
Interventions
- DIAGNOSTIC_TEST No Intervention-Clinical Assessments only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-11-09 |
| Est. Completion | 2023-04-24 |
Why NCT05063474 stopped before completion
NCT05063474 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No Intervention-Clinical Assessments only is the first listed.
NCT05063474 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05063474 about?
NCT05063474 is a clinical study titled "Microvascular Reactivity in Peripheral Artery Disease". Peripheral Artery Disease (PAD) is a major risk factor for lower limb amputation. Microvascular reactivity assessed with near-infrared spectrometry has been studied in people with PAD but not in people with limb loss (PLL) who have PAD. The purpose of this research is to explore whether near-infrare...
What is the current status of trial NCT05063474?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2021-11-09. Estimated completion is 2023-04-24.
What interventions are being tested in trial NCT05063474?
The interventions under investigation include: No Intervention-Clinical Assessments only (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05063474?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI